Review Article

Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization—A Meta-Analysis

Table 1

Demographics and specific results of all studies included in this meta-analysis.

ReferenceYearInclusion periodCountryNumber of patients 
(HR/TACE)
M/F 
(HR/TACE)
Mean age (years)Mean AFP (ng/mL)Child-Pugh 
A 
B 
C
Tumor size (cm)Bilirubin total (mg/dL)Albumin (g/dL)Tumor number  
(HR/TACE)

Choi et al. [13]20132003–2008South Korea36/10734/2 
86/21
54.3 ± 8.6 
61.2 ± 9.3
≤3 19/17  
≥3 29/78
4.05 ± 0.5 
3.93 ± 0.48
2 : 30/2 : 90 
3 : 6/3 : 17
Ho et al. [14]20091981–2000Taiwan294/367240/54 
290/77
57.0 ± 11.8 
60.1 ± 12.3
8216 ± 55270 
13464 ± 65879
229/234  
13/49  
0/9
5.0 ± 3.5/5.3 ± 3.51.2 ± 1.9 
1.3 ± 1.4
3.8 ± 0.5 
3.5 ± 0.5
Hsu et al. [15] 20122001–2007Taiwan112/7376/39 
60.3 ± 11.7 
61.9 ± 11.7
≥200 30/13 
≤200 82/60
2.48 ± 0.69 
2.34 ± 0.74
0.81 ± 0.33 
0.91 ± 0.45
3.98 ± 0.45 
3.87 ± 0.41
S: 41/S: 83 
M: 32/M: 29
Lee et al. [16]20021993–1994Korea 91/9176/15 
79/12
50 ± 10 
65 ± 10
<400 8/60 
≥400 33/31
Lin et al. [17]20102001–2007Taiwan93/7375/18 
53/25
59 ± 15.6 
62 ± 12.9
≥400 45/35 
<400 48/43
8.0 ± 3.3 
7.7 ± 4.4
1.8 ± 1.2 
1.3 ± 1.3
3.8 ± 0.5 
3.3 ± 0.5
S: 49/S: 22 
M: 44/M: 56
Luo et al. [18]20112004–2006China85/8370/15 
79/4
47.5 ± 12.8 
50.9 ± 11.2
238.5 (0–121000) 
306.6 (0.6–121000)
60/71 
4/1
8.7 ± 3.5 (5–20)  
7.8 ± 2.5 (5–15)
15.8 ± 6.9 
17.1 ± 7.4
4.05 ± 0.36 
4.16 ± 0.40
2 : 35/2 : 32 
3 : 20/3 : 11 
>4 : 30/>4 : 40
Peng et al. [19]20122002–2007China201/402187/14 
374/28
55 (25–75) 
55 (23–75)
562.3 
598.5
197/389 
4/13
≤5 76/178 
≥5 125/224
1.29 
1.25
3.68 
3.63
1 : 95/1 : 132 
>1.106/>1 : 270
Sasaki et al. [20] 19981980–1994Japan384/5343.7 
4.7
60 ± 8.4 
62 ± 7.4
3.9 ± 3.3  
5.4 ± 3.7
0.8 ± 0.4 
1.1 ± 0.5
3.7 ± 0.4 
3.6 ± 0.5
2-3 : 26/2-3 : 33 
<4 : 0/<4 : 2
Sotiropoulos et al. [21] 200961/64
Utsunomiya et al. [22]20142000–2005Japan2872/14372332/540 
1124/313
67 (50, 79) 
69 (53, 83)
3491 (15, 16368) 
3177 (15, 13605)
2679/1068 
193/369
5.8 (1.8, 14) 
5.0 (1.4, 13)
0.8 (0.4, 1.5) 
1.1 (0.4, 2.3)
4.0 (3.2, 4.7) 
3.7 (2.8, 4.5)
1 : 2193/1 : 316 
2 : 323/2 : 85 
>3 : 126/>3 : 28
Zhong et al. 1 [8] 20142000–2007China908/351824/84 
326/25
44 (17–78) 
53 (19–82)
≥400 434/158 
≤400 474/193
8 (4–20)/10 (4–20)1.3 (0.5–4.0) 
1.7 (0.3–22)
3.9 (2.8–4.7) 
3.9 (2.2–5.1)
<3845/<3 : 319 
>3 : 63/>3 : 32
Zhong et al. 2 [23]20132000–2007China257/135233/24 
127/8
46.8 ± 12.0 
48.7 ± 12.5
≥400 143/66 
≤400 114/69
8.9 ± 3.0 
8.8 ± 2.5
14.5 ± 5.3 
15.1 ± 8.5
S: 199/S: 104 
M: 85/M: 31